Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Cost of Revenue (2024 - 2026)

Invivyd's (IVVD) quarterly Cost of Revenue came in at $1.3 million in Q2 2026, up 85.84% on a YoY basis from $685000.0 in Q2 2025, and up 11.67% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Invivyd (IVVD) Cost of Revenue (2024 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Cost of Revenue for 3 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cost of Revenue rose 85.84% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (up 37.29% YoY), and the FY2025 full-year result was $3.7 million, up 131.58% from the prior year.
  • Cost of Revenue advanced to $1.3 million in Q2 2026 per IVVD's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.3 million in Q2 2026 and bottomed at $88000.0 in Q2 2024.
  • Historically, Cost of Revenue has averaged $829750.0 across 3 years, with a median of $820000.0 in 2024.
  • The widest YoY moves for Cost of Revenue: up 678.41% in 2025, down 34.99% in 2025.
  • Over 3 years, Cost of Revenue stood at $724000.0 in 2024, then soared by 57.46% to $1.1 million in 2025, then climbed by 11.67% to $1.3 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $1.3 million, $1.1 million, and $1.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.81 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 1.58 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 489.20 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 360.70 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 145.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 93.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 298.26 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 776.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 67.21 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 1.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.27 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 1.09 Mn
Jun 30, 2025 685,000.00
Mar 31, 2025 834,000.00
Dec 31, 2024 724,000.00
Sep 30, 2024 806,000.00
Jun 30, 2024 88,000.00